Other
Rituximab
B-cell inhibitor, biologic
Other names: Rituxan
Wait
2 weeks
ground trial when starting
Different waits apply in other cases.
Examiner
The examiner can issue when the document's criteria are met
FAA label
ACCEPTABLE
The FAA lists rituximab as an acceptable biologic when the underlying condition qualifies, with a two-week ground trial when starting and 72 hours of no-fly after each dose.
Track your medicationsMore detail: rituximabThe rest of Crosscheck's reading, in plain wordsOpen
Wait
- 72 hours no-fly after each dose
- a forty-eight hour ground trial when changing from one biologic or biosimilar to another for the same indication
Changing from one biologic or biosimilar to another for the same indication requires a 48-hour ground trial.
- 14 days after starting: ground observation
- 72 hours after each dose: no flying
Show the FAA's words: rituximabThe official FAA wording: two passages, each with its document and dateOpen
Observation times: Required ground trial and/or no-fly after each dose. Initial observation: All require a 2-week no-fly/ground trial to verify no side effects.
ACCEPTABLE BIOLOGICS - MONOTHERAPY MEDICATION Permitted if the underlying condition qualifies; consult the condition pages for details.
B-Cell Inhibitors: rituximab (Rituxan), 72 hours
Changing from one biologic/biosimilar to another for the same indication requires a forty-eight (48) hour ground trial to mitigate any aeromedical risk.